Research Paper Volume 14, Issue 5 pp 2320—2334
Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma
Figure 2. (A) IHC illustration of PLK expression levels in GBM (HPA). (B) Immunohistochemical staining of PLKs in gliomas.